Tagged Articles

patent 4 articles

Testim maker files patent infringement lawsuit

Auxilium Pharmaceuticals, the maker of Testim® 1%, has filed a lawsuit against Watson Laboratories Inc. and related companies for allegedly violating patents protecting its best-selling testosterone replacement gel. Auxilium and FCB I LLC, a subsidiary of Xstelos Holdings Inc., filed the lawsuit in U.S. District Court for the District of New Jersey on May 23, accusing Watson Laboratories, Watson Pharmaceuticals, Inc. and Watson Pharma Inc. of infringing on 10 Testim® patents listed in the U.S. Food and Drug Administration’s Approved Drug Products with Therapeutic Equivalence Evaluations, better known in the industry as the FDA’s “Orange Book.” According to Auxilium, the ... Read More

Actos patent expiration sets Takeda on acquisitions hunt

Faced with sharply dwindling profits, Japan’s Takeda Pharmaceutical Co. has gone on an international shopping spree in search of drug company acquisitions that would introduce new drugs to the Takeda line and help offset a cash crunch brought about by the patent expiration on its diabetes drug Actos and other key drugs. Takeda, the largest pharmaceutical company in Asia, has spent almost $15 billion in overseas acquisitions in less than two years and has its sights set on other companies that could give it a needed boost. Last year, the company paid $13.7 million for the Swiss company Nycomed, which ... Read More

Actos maker to buy gout treatment manufacturer

Japanese drug maker Takeda Pharmaceuticals Co. is hoping an $800 million acquisition of U.S. gout treatment maker URL Pharma Inc. will boost the company’s U.S. sales and, ideally, cover ground lost with its blockbuster type 2 diabetes drug Actos. Not only does Actos lose its patent protection later this year, paving the way for generic competition, sales of the drug have slumped since last year, when the Food and Drug Administration (FDA) warned that studies have linked the diabetes treatment to bladder cancer. Takeda is Japan’s largest drug maker, but the majority of its sales come from the United States ... Read More

UK blocks sales of generic Yasmin

Europe’s biggest drug company, Bayer AG, has won a lawsuit in the United Kingdom, protecting the patent on its birth control pill Yasmin against a challenge by Hungary’s Gedeon Richter Nyrt. Justice Christopher Floyd ruled in the High Court of London that the inventions the patents covered for Yasmin would not have been “obvious” to experts in the industry. The ruling is in contrast to a case in the United States in 2008, in which the Yasmin patent was found to be invalid because it was “obvious” to other experts in the field. That ruling opened the door for Israel’s ... Read More